Asia Pacific Veterinary Oncology Market By Animal Type (Canine and Feline) By Therapy (Chemotherapy, Radiology, Surgery, Immunotherapy and Others) By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others) By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Veterinary oncology Market would witness market growth of 14.6% CAGR during the forecast period (2020-2026).
Cancers are among the most common diseases that affect dogs. Some of them arise naturally and exhibit certain parallels to human cancers in their physiology and histopathology. There is more, it is seen that there are many more analogies between these two species in the molecular pathways of cancer development. Human oncology is finding more and more effective approaches to diagnose an early illness that results directly in the increased life span of infected animals.
One of the most common trends of cancer treatment is the presence of circulating tumor cells (CTC) of patient blood. These cells are known to be responsible for the development of metastases in distant organs which results in patient death. It is also known that CTC is still present in the early stages of tumor growth in the bloodstream of patients. There is no evidence that the cause for the production of metastasis in dogs is similar, and that the CTC is still found in their bloodstream. Despite rigorous research, there is still no ideal way to separate cancer cells from the blood where they barely exist.
The growing prevalence of zoonotic and foodborne diseases worldwide has driven companies to establish successful testing solutions for both animals and pets. In fact, growth in the demand for veterinary diagnostics is supported by growing spending on animal healthcare and a favorable regulatory scenario for diagnostic approval. The growing use of in vitro diagnostic tests and advanced innovations like nanotechnology, fluorometric diagnosis, biosensors, wearables, and biomarkers has helped this market grow. Research centers and laboratories also report a surge in demand for in-house equipment and techniques for diagnosis.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Scope of the Study
Market Segmentation:
By Animal Type
Cancers are among the most common diseases that affect dogs. Some of them arise naturally and exhibit certain parallels to human cancers in their physiology and histopathology. There is more, it is seen that there are many more analogies between these two species in the molecular pathways of cancer development. Human oncology is finding more and more effective approaches to diagnose an early illness that results directly in the increased life span of infected animals.
One of the most common trends of cancer treatment is the presence of circulating tumor cells (CTC) of patient blood. These cells are known to be responsible for the development of metastases in distant organs which results in patient death. It is also known that CTC is still present in the early stages of tumor growth in the bloodstream of patients. There is no evidence that the cause for the production of metastasis in dogs is similar, and that the CTC is still found in their bloodstream. Despite rigorous research, there is still no ideal way to separate cancer cells from the blood where they barely exist.
The growing prevalence of zoonotic and foodborne diseases worldwide has driven companies to establish successful testing solutions for both animals and pets. In fact, growth in the demand for veterinary diagnostics is supported by growing spending on animal healthcare and a favorable regulatory scenario for diagnostic approval. The growing use of in vitro diagnostic tests and advanced innovations like nanotechnology, fluorometric diagnosis, biosensors, wearables, and biomarkers has helped this market grow. Research centers and laboratories also report a surge in demand for in-house equipment and techniques for diagnosis.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Scope of the Study
Market Segmentation:
By Animal Type
- Canine and
- Feline
- Chemotherapy
- Radiology
- Surgery
- Immunotherapy and
- Others
- Lymphoma
- Mast Cell Cancer
- Mammary & Squamous Cell Cancer and
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Boehringer Ingelheim International GmbH
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Varian Medical Systems, Inc.
- PetCure Oncology, LLC (Accelitech, LLC)
- AB Science SA
- Rhizen Pharmaceuticals S.A.
- Nippon Zenyaku Kogyo Co., Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Veterinary Oncology Market, by Animal Type
1.4.2 Asia Pacific Veterinary Oncology Market, by Therapy
1.4.3 Asia Pacific Veterinary Oncology Market, by Cancer Type
1.4.4 Asia Pacific Veterinary Oncology Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players
CHAPTER 4. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE
4.1 Asia Pacific Canine Market by Country
4.2 Asia Pacific Feline Market by Country
CHAPTER 5. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY
5.1 Asia Pacific Chemotherapy Market by Country
5.2 Asia Pacific Radiology Market by Country
5.3 Asia Pacific Surgery Market by Country
5.4 Asia Pacific Immunotherapy Market by Country
5.5 Asia Pacific Other Therapy Market by Country
CHAPTER 6. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE
6.1 Asia Pacific Lymphoma Market by Country
6.2 Asia Pacific Mast Cell Cancer Market by Country
6.3 Asia Pacific Mammary & Squamous Cell Cancer Market by Country
6.4 Asia Pacific Others Market by Country
CHAPTER 7. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY
7.1 China Veterinary Oncology Market
7.1.1 China Veterinary Oncology Market by Animal Type
7.1.2 China Veterinary Oncology Market by Therapy
7.1.3 China Veterinary Oncology Market by Cancer Type
7.2 Japan Veterinary Oncology Market
7.2.1 Japan Veterinary Oncology Market by Animal Type
7.2.2 Japan Veterinary Oncology Market by Therapy
7.2.3 Japan Veterinary Oncology Market by Cancer Type
7.3 India Veterinary Oncology Market
7.3.1 India Veterinary Oncology Market by Animal Type
7.3.2 India Veterinary Oncology Market by Therapy
7.3.3 India Veterinary Oncology Market by Cancer Type
7.4 South Korea Veterinary Oncology Market
7.4.1 South Korea Veterinary Oncology Market by Animal Type
7.4.2 South Korea Veterinary Oncology Market by Therapy
7.4.3 South Korea Veterinary Oncology Market by Cancer Type
7.5 Singapore Veterinary Oncology Market
7.5.1 Singapore Veterinary Oncology Market by Animal Type
7.5.2 Singapore Veterinary Oncology Market by Therapy
7.5.3 Singapore Veterinary Oncology Market by Cancer Type
7.6 Malaysia Veterinary Oncology Market
7.6.1 Malaysia Veterinary Oncology Market by Animal Type
7.6.2 Malaysia Veterinary Oncology Market by Therapy
7.6.3 Malaysia Veterinary Oncology Market by Cancer Type
7.7 Rest of Asia Pacific Veterinary Oncology Market
7.7.1 Rest of Asia Pacific Veterinary Oncology Market by Animal Type
7.7.2 Rest of Asia Pacific Veterinary Oncology Market by Therapy
7.7.3 Rest of Asia Pacific Veterinary Oncology Market by Cancer Type
CHAPTER 8. COMPANY PROFILES
8.1 Boehringer Ingelheim International GmbH
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.5.2 Partnerships, Collaborations, and Agreements:
8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
8.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Veterinary Oncology Market, by Animal Type
1.4.2 Asia Pacific Veterinary Oncology Market, by Therapy
1.4.3 Asia Pacific Veterinary Oncology Market, by Cancer Type
1.4.4 Asia Pacific Veterinary Oncology Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players
CHAPTER 4. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE
4.1 Asia Pacific Canine Market by Country
4.2 Asia Pacific Feline Market by Country
CHAPTER 5. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY
5.1 Asia Pacific Chemotherapy Market by Country
5.2 Asia Pacific Radiology Market by Country
5.3 Asia Pacific Surgery Market by Country
5.4 Asia Pacific Immunotherapy Market by Country
5.5 Asia Pacific Other Therapy Market by Country
CHAPTER 6. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE
6.1 Asia Pacific Lymphoma Market by Country
6.2 Asia Pacific Mast Cell Cancer Market by Country
6.3 Asia Pacific Mammary & Squamous Cell Cancer Market by Country
6.4 Asia Pacific Others Market by Country
CHAPTER 7. ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY
7.1 China Veterinary Oncology Market
7.1.1 China Veterinary Oncology Market by Animal Type
7.1.2 China Veterinary Oncology Market by Therapy
7.1.3 China Veterinary Oncology Market by Cancer Type
7.2 Japan Veterinary Oncology Market
7.2.1 Japan Veterinary Oncology Market by Animal Type
7.2.2 Japan Veterinary Oncology Market by Therapy
7.2.3 Japan Veterinary Oncology Market by Cancer Type
7.3 India Veterinary Oncology Market
7.3.1 India Veterinary Oncology Market by Animal Type
7.3.2 India Veterinary Oncology Market by Therapy
7.3.3 India Veterinary Oncology Market by Cancer Type
7.4 South Korea Veterinary Oncology Market
7.4.1 South Korea Veterinary Oncology Market by Animal Type
7.4.2 South Korea Veterinary Oncology Market by Therapy
7.4.3 South Korea Veterinary Oncology Market by Cancer Type
7.5 Singapore Veterinary Oncology Market
7.5.1 Singapore Veterinary Oncology Market by Animal Type
7.5.2 Singapore Veterinary Oncology Market by Therapy
7.5.3 Singapore Veterinary Oncology Market by Cancer Type
7.6 Malaysia Veterinary Oncology Market
7.6.1 Malaysia Veterinary Oncology Market by Animal Type
7.6.2 Malaysia Veterinary Oncology Market by Therapy
7.6.3 Malaysia Veterinary Oncology Market by Cancer Type
7.7 Rest of Asia Pacific Veterinary Oncology Market
7.7.1 Rest of Asia Pacific Veterinary Oncology Market by Animal Type
7.7.2 Rest of Asia Pacific Veterinary Oncology Market by Therapy
7.7.3 Rest of Asia Pacific Veterinary Oncology Market by Cancer Type
CHAPTER 8. COMPANY PROFILES
8.1 Boehringer Ingelheim International GmbH
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.5.2 Partnerships, Collaborations, and Agreements:
8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
8.10.1 Company Overview
LIST OF TABLES
TABLE 1 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 5 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 6 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 7 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 8 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 9 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 10 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 11 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 12 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 13 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 14 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 15 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 16 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 17 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 18 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 19 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 20 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 21 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 22 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 23 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 24 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 25 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 26 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 27 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 28 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 29 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 30 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 31 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 32 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 33 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 34 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 35 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 36 CHINA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 37 CHINA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 38 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 39 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 40 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 41 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 42 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 43 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 44 JAPAN VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 45 JAPAN VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 46 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 47 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 48 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 49 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 50 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 51 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 52 INDIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 53 INDIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 54 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 55 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 56 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 57 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 58 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 59 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 60 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 61 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 62 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 63 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 64 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 65 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 66 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 67 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 68 SINGAPORE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 69 SINGAPORE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 70 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 71 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 72 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 73 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 74 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 75 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 76 MALAYSIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 77 MALAYSIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 78 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 79 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 80 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 81 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 82 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 83 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 84 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 85 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 86 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 87 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 88 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 89 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 90 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 91 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 92 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 93 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 94 KEY INFORMATION – REGENEUS LTD.
TABLE 95 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 96 KEY INFORMATION – ZOETIS, INC.
TABLE 97 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 98 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 99 KEY INFORMATION – AB SCIENCE SA
TABLE 100 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 101 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.
TABLE 1 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 5 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 6 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 7 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 8 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 9 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 10 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 11 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 12 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 13 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 14 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 15 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 16 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 17 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 18 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 19 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 20 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 21 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 22 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 23 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 24 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 25 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 26 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 27 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 28 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 29 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 30 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 31 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 32 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 33 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 34 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 35 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 36 CHINA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 37 CHINA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 38 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 39 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 40 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 41 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 42 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 43 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 44 JAPAN VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 45 JAPAN VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 46 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 47 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 48 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 49 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 50 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 51 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 52 INDIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 53 INDIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 54 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 55 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 56 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 57 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 58 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 59 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 60 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 61 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 62 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 63 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 64 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 65 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 66 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 67 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 68 SINGAPORE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 69 SINGAPORE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 70 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 71 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 72 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 73 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 74 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 75 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 76 MALAYSIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 77 MALAYSIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 78 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 79 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 80 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 81 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 82 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 83 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 84 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 85 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 86 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 87 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 88 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 89 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 90 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 91 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 92 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 93 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 94 KEY INFORMATION – REGENEUS LTD.
TABLE 95 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 96 KEY INFORMATION – ZOETIS, INC.
TABLE 97 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 98 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 99 KEY INFORMATION – AB SCIENCE SA
TABLE 100 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 101 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.
